Nothing Special   »   [go: up one dir, main page]

GB0026834D0 - Method for detecting inhibitors of tumour growth - Google Patents

Method for detecting inhibitors of tumour growth

Info

Publication number
GB0026834D0
GB0026834D0 GBGB0026834.2A GB0026834A GB0026834D0 GB 0026834 D0 GB0026834 D0 GB 0026834D0 GB 0026834 A GB0026834 A GB 0026834A GB 0026834 D0 GB0026834 D0 GB 0026834D0
Authority
GB
United Kingdom
Prior art keywords
tumour growth
detecting inhibitors
inhibitors
detecting
tumour
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0026834.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consejo Superior de Investigaciones Cientificas CSIC
Original Assignee
Consejo Superior de Investigaciones Cientificas CSIC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior de Investigaciones Cientificas CSIC filed Critical Consejo Superior de Investigaciones Cientificas CSIC
Priority to GBGB0026834.2A priority Critical patent/GB0026834D0/en
Publication of GB0026834D0 publication Critical patent/GB0026834D0/en
Priority to PCT/GB2001/004891 priority patent/WO2002036818A2/en
Priority to AU2002212494A priority patent/AU2002212494A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5076Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/20Screening for compounds of potential therapeutic value cell-free systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0026834.2A 2000-11-02 2000-11-02 Method for detecting inhibitors of tumour growth Ceased GB0026834D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0026834.2A GB0026834D0 (en) 2000-11-02 2000-11-02 Method for detecting inhibitors of tumour growth
PCT/GB2001/004891 WO2002036818A2 (en) 2000-11-02 2001-11-02 Method for detecting inhibitors of tumour growth
AU2002212494A AU2002212494A1 (en) 2000-11-02 2001-11-02 Method for detecting inhibitors of tumour growth

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0026834.2A GB0026834D0 (en) 2000-11-02 2000-11-02 Method for detecting inhibitors of tumour growth

Publications (1)

Publication Number Publication Date
GB0026834D0 true GB0026834D0 (en) 2000-12-20

Family

ID=9902458

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0026834.2A Ceased GB0026834D0 (en) 2000-11-02 2000-11-02 Method for detecting inhibitors of tumour growth

Country Status (3)

Country Link
AU (1) AU2002212494A1 (en)
GB (1) GB0026834D0 (en)
WO (1) WO2002036818A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002044344A2 (en) * 2000-11-28 2002-06-06 Curis, Inc. Basal cell carcinoma cultures, methods related thereto and their use
WO2006080894A2 (en) * 2005-01-31 2006-08-03 Karolinska Institutet Innovations Ab Hedgehog inhibitor assay
ES2302625B1 (en) * 2006-09-30 2009-05-29 Consejo Sup. De Invest. Cientificas NON-HUMAN ANIMAL MODEL USEFUL FOR THE IDENTIFICATION OF PHARMACEUTICAL COMPOUNDS REGULATING THE VIA HEDGEHOG, PROCEDURE OF OBTAINING AND ITS USE IN A PROCEDURE OF IDENTIFICATION OF PHARMACEUTICAL COMPOUNDS REGULATING THE VIA HEDGEHOG.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE286033T1 (en) * 1999-09-16 2005-01-15 Curis Inc BROKERS OF IGEL SIGNAL PATHS, THEIR COMPOSITIONS AND USES

Also Published As

Publication number Publication date
WO2002036818A2 (en) 2002-05-10
AU2002212494A1 (en) 2002-05-15
WO2002036818A3 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
HUP0304039A3 (en) Methods for preparing cetp inhibitors
PL344108A1 (en) Process for synthesizing cox-2 inhibitors
AU3416200A (en) Method for determining the concentration of thrombin inhibitors
HK1038796B (en) Method of earth-resistance measurement
GB2385421B (en) Method of measuring anaerobic threshold
AU1036601A (en) Method of screening for inhibitors of asp1
GB0006191D0 (en) Method for acquisition of slot timing
EP1292305A4 (en) METHOD OF DOPAMINE INHIBITION USING i L-THREO /i -METHYLPHENIDATE
HK1053844A1 (en) Method of identifying inhibitors of tie-2
GB0026834D0 (en) Method for detecting inhibitors of tumour growth
IL137208A0 (en) Method for depth profiling of a sample
AU2001270131A1 (en) Screen for identifying inhibitors of glycosylphosphatidylnositol anchoring
HUP0103554A2 (en) Method for production of methylene-karbamide polimers
AU2003284140A8 (en) Method for inhibiting angiogenesis with ship-1 inhibitors
PL376796A1 (en) Method of preparing inhibitors of phosphodiesterase-4
GB0029539D0 (en) Method for identifying modulatorss of transcription
AU2001236440A1 (en) Method for the treatment of inflammation with spla2 inhibitors
AU2001246862A1 (en) Method of detecting cancer
AU4021700A (en) Methods of use of beta1-integrin inhibitors
AU1073001A (en) Method of identifying inhibitors of cdc25
GB9923761D0 (en) Method for identifying inhibitors
GB0029379D0 (en) A method for identifying enzyme inhibitors
AU2001290852A1 (en) Inhibitors of rho c
AU2001229252A1 (en) Method for the treatment of renal dysfunction with spla2 inhibitors
AU2000252853A1 (en) Apparatus and method for inhibiting lesion formation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)